Interaction of CRF and Kappa Opioid Systems on GABAergic Neurotransmission in the Mouse Central Amygdala

The corticotropin-releasing factor (CRF) and kappa-opioid receptor (KOR) systems are both implicated in stress-related behaviors and drug dependence. Although previous studies suggest that antagonism of each system blocks aspects of experimental models of drug dependence, the possible interaction between these systems at the neuronal level has not been completely examined. We used an in vitro brain slice preparation to investigate the interaction of these two peptide systems on inhibitory neurotransmission in the central nucleus of the amygdala (CeA). Application of exogenous CRF increased the mean frequency of GABAergic miniature inhibitory postsynaptic currents (mIPSC) by 20.2%, suggesting an increase in presynaptic GABA release. Although the pharmacological blockade of KORs by norBNI alone did not significantly affect mIPSC frequency, it significantly enhanced the effect of CRF (by 43.9%, P = 0.02). Similarly, the CRF effects in slices from KOR knockout (KO) mice (84.0% increase) were significantly greater than in wild-type (WT) mice (24.6%, P = 0.01), although there was no significant difference in baseline mIPSC frequency between slices from KOR KO and WT mice. The increase in CRF action in the presence of norBNI was abolished by a CRF-1 receptor antagonist but was unaffected by a CRF-2 receptor antagonist. We hypothesize that CRF facilitates the release of an endogenous ligand for KORs and that subsequent activation of KOR receptors modulates presynaptic effects of CRF in CeA. These results suggest that potential pharmacotherapies aimed at neurobehavioral and addictive disorders may need to involve both the KOR/dynorphin and the CRF systems in CeA.

[1]  M. Roberto,et al.  The Central Amygdala as an Integrative Hub for Anxiety and Alcohol Use Disorders , 2015, Biological Psychiatry.

[2]  Anna B. Rachlin,et al.  Sex Differences in Sensitivity to the Depressive-like Effects of the Kappa Opioid Receptor Agonist U-50488 in Rats , 2014, Biological Psychiatry.

[3]  B. Trainor,et al.  Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females , 2014, Behavioural Brain Research.

[4]  A. Lê,et al.  The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats , 2014, Brain and behavior.

[5]  G. Koob,et al.  Addiction as a stress surfeit disorder , 2014, Neuropharmacology.

[6]  G. Koob,et al.  Long-Term Antagonism of κ Opioid Receptors Prevents Escalation of and Increased Motivation for Heroin Intake , 2013, The Journal of Neuroscience.

[7]  G. Gessa,et al.  Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats , 2013, Neuroscience Letters.

[8]  S. D. Moore,et al.  κ-Opioid Receptors in the Central Amygdala Regulate Ethanol Actions at Presynaptic GABAergic Sites , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[9]  G. Paxinos,et al.  Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates , 2012 .

[10]  C. Gianoulakis,et al.  Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala. , 2011, Alcohol.

[11]  M. Wessendorf,et al.  Spinal Synthesis of Estrogen and Concomitant Signaling by Membrane Estrogen Receptors Regulate Spinal κ- and μ-Opioid Receptor Heterodimerization and Female-Specific Spinal Morphine Antinociception , 2011, The Journal of Neuroscience.

[12]  K. Miczek,et al.  Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA , 2011, Psychopharmacology.

[13]  G. Koob,et al.  Systemic κ‐opioid receptor antagonism by nor‐binaltorphimine reduces dependence‐induced excessive alcohol self‐administration in rats , 2011, Addiction biology.

[14]  A. Thompson,et al.  Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia , 2010, PAIN®.

[15]  A. Gintzler,et al.  Formation of μ-/κ-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia , 2010, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Hodge,et al.  CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA Axis , 2010, Neuropsychopharmacology.

[17]  L. Parsons,et al.  Corticotropin Releasing Factor–Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol Dependence , 2010, Biological Psychiatry.

[18]  M. Bruchas,et al.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors , 2010, Brain Research.

[19]  Julia C. Lemos,et al.  CRF1-R Activation of the Dynorphin/Kappa Opioid System in the Mouse Basolateral Amygdala Mediates Anxiety-Like Behavior , 2009, PloS one.

[20]  C. Schwarzer,et al.  Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone , 2009, Neuropsychopharmacology.

[21]  G. Koob,et al.  Pharmacological Evidence for a Motivational Role of κ-Opioid Systems in Ethanol Dependence , 2008, Neuropsychopharmacology.

[22]  Julia C. Lemos,et al.  The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System , 2008, The Journal of Neuroscience.

[23]  G. Valdez,et al.  κ Agonist-Induced Reinstatement of Cocaine Seeking in Squirrel Monkeys: A Role for Opioid and Stress-Related Mechanisms , 2007, Journal of Pharmacology and Experimental Therapeutics.

[24]  Nathan J. Marchant,et al.  Coexpression of prodynorphin and corticotrophin‐releasing hormone in the rat central amygdala: Evidence of two distinct endogenous opioid systems in the lateral division , 2007, The Journal of comparative neurology.

[25]  G. Koob,et al.  A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats , 2007, Brain Research.

[26]  G. Koob,et al.  Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent Rats , 2007, Biological Psychiatry.

[27]  F. Papaleo,et al.  The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. D. Moore,et al.  Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors , 2004, Science.

[29]  C. Drake,et al.  Kappa opioid receptors in rat spinal cord vary across the estrous cycle , 2000, Brain Research.

[30]  B. Roques,et al.  Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawal , 1998, The EMBO journal.

[31]  A. Takemori,et al.  Stimulation by corticotropin-releasing factor of the release of immunoreactive dynorphin A from mouse spinal cords in vitro. , 1992, European journal of pharmacology.

[32]  D. Sirinathsinghji,et al.  Corticotropin-releasing factor stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo studies , 1989, Brain Research.

[33]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[34]  K. Ressler,et al.  Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes , 2009, Molecular Psychiatry.

[35]  G. Koob,et al.  Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. , 2008, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[36]  A. Herz,et al.  Regulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (CRF). , 1986, NIDA research monograph.